Carasent (CARA) M&A Announcement summary

Deal rationale and strategic fit

• Acquisition targets entry into Germany, Europe's largest healthcare market, leveraging Data-AL's strong local presence, customer base, and regulatory knowledge.

• Data-AL's focus on EHR solutions for private clinics aligns with the buyer's Webdoc product and strategic expansion goals.

• The deal provides a foundation for rolling out Webdoc X in Germany, supporting long-term growth strategy.

Financial terms and conditions

• Full acquisition of Data-AL for €8 million enterprise value, with up to €4 million additional earn-out based on future growth.

• Data-AL reported €4 million revenue and €0.5 million EBITDA in 2023.

• Deal financed from existing cash; signing and closing occurred simultaneously.

Synergies and expected cost savings

• Integration expected to optimize pricing and cost structure, potentially increasing margins as seen in previous acquisitions.

• Cloud migration anticipated to double per-customer revenue, based on Nordic market experience.

• Data-AL's stable, recurring revenue and low customer churn offer a solid base for long-term growth.